Results 201 to 210 of about 86,474 (255)

Weight cycling and cancer risk in the Sister Study. [PDF]

Am J Epidemiol
Stevens VL, Priest J, Wilkerson J, D'Aloisio AA, Sandler DP.   +4 more
europepmc   +1 more source

Impact of <i>IGF2BP2</i> genetic variants and expression levels with the progression of endometrial cancer. [PDF]

Int J Med Sci
Kan CY, Sun YH, Lee CY, Su SC, Chang CC, Tang CH, Chu HJ, Wang PH, Yang SF.   +8 more
europepmc   +1 more source

Hereditary cancer syndromes with gynecological cancer risk: focus on prevention strategies. [PDF]

Front Oncol
Duranti S, Iacobelli V, Trozzi R, Camarda F, Panfili A, Fagotti A, Fanfani F, Marchetti C, Nero C.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Expression of androgen receptors in benign and malignant endometrial stromal neoplasms

Virchows Archiv Fur Pathologische Anatomie Und Physiologie Und Fur Klinische Medizin, 2004
Several studies have shown that endometrial stromal neoplasms express estrogen and progesterone receptors (ER, PR). To our knowledge, the presence or absence of androgen receptors (AR) in these rare uterine neoplasms has not been investigated. Tumors ( n=20)-3 endometrial stromal nodules, 14 low-grade endometrial stromal sarcomas (ESS, low grade), and ...
Fattaneh A Tavassoli, Denk Helmut, Moinfar Farid   +2 more
exaly   +3 more sources

CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms

Histopathology, 2001
CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms Aims: The CD10 antigen is expressed in acute lymphoblastic leukaemia and follicle centre cell lymphoma. A recent study investigating the expression of CD10 in a wide range of non‐haematopoietic neoplasms found ...
W G, McCluggage, V P, Sumathi, P, Maxwell   +2 more
exaly   +3 more sources

Recent advances in the histological and molecular classification of endometrial stromal neoplasms

Virchows Archiv Fur Pathologische Anatomie Und Physiologie Und Fur Klinische Medizin, 2018
This review addresses known features and recent developments in the histological, immunohistochemical, and molecular characterization of endometrial stromal neoplasms. We discuss the spectrum of these tumors, from the benign endometrial stromal nodule to low-grade endometrial stromal sarcoma to uterine undifferentiated sarcomas with a special emphasis ...
Ana Felix, Joana Ferreira
exaly   +3 more sources

Computed Tomography in Malignant Endometrial Neoplasms

Journal of Computer Assisted Tomography, 1983
Malignant uterine neoplasms are the most common invasive gynecological malignancies. The prognosis depends on the history, the grade, and the stage. Recent reports have stressed that a small percentage of patients with clinically low stage disease have unsuspected metastases.
D M, Balfe, J, Van Dyke, J K, Lee, P J, Weyman, B L, McClennan   +4 more
openaire   +2 more sources

An Unusual Endometrial Stromal Neoplasm With JAZF1-BCORL1 Rearrangement

International Journal of Gynecological Pathology, 2023
Endometrial stromal tumors represent the second most common category of uterine mesenchymal tumors. Several different histologic variants and underlying genetic alterations have been recognized, one such being a group associated with BCORL1 rearrangements.
Parnian A, Moghaddam, Robert H, Young, Nadia D, Ismiil, Jennifer A, Bennett, Esther, Oliva   +4 more
openaire   +2 more sources